Vasundhara Rasayan Peer Comparison

BSE: 538634

₹139.75

₹0.70 (0.50%)

As on 16-Oct-2026IST

Market cap

₹44 Cr

Revenue (TTM)

₹35 Cr

P/E Ratio

7.5

P/B Ratio

1.1

Div. Yield

1.4 %

Edit

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Market cap (₹ Cr)	44	95	68	33,322	21,803
Revenue (₹ Cr)	35	18	1	5,595	8,575
Net Profit (₹ Cr)	5.90	-1.19	1.49	859.32	783.41
Net Margin (%)	15.67	-5.82	67.60	14.81	9.08
RoE (%)	14.76	--	3.36	17.37	13.96
Price to Earnings	7.52	--	45.82	38.98	27.84
Price-To-Book	1.07	13.94	1.50	6.49	3.53

Income Statement (₹ Cr)

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Operating Revenue	35.72	28.20	6.16	4,660.70	7,887.07
Total Income	38.63	28.24	6.18	4,831.99	7,946.94
Total Expenditure	29.88	27.95	5.56	3,698.56	6,903.20
EBITDA	5.84	0.25	0.60	962.14	983.87
Depreciation	0.43	1.03	0.03	68.16	224.64
EBIT	5.41	-0.78	0.56	893.98	759.23
Interest	0.45	0.59	0.00	64.37	49.17
Other Income	2.90	0.04	0.02	171.30	59.87
Exceptional Items	--	-1.07	--	--	-12.84
Profit before Tax	7.86	-2.40	0.58	1,000.91	757.09
Provision for Tax	2.07	-0.30	0.15	245.83	206.43
Profit after Tax	5.79	-2.09	0.43	755.07	550.66

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Shareholder's Funds	40.88	-1.99	44.83	4,706.68	5,836.83
Minority Interest	--	--	--	55.40	32.45
Non-Current Liabilities	0.41	7.51	1.38	308.73	1,505.33
Current Liabilities	6.60	13.04	0.69	1,452.28	1,278.74
Total Liabilities	47.88	18.75	46.92	6,523.10	8,653.35

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Non-Current Assets	2.54	8.56	0.05	3,483.44	5,583.97
Current Assets	45.34	10.00	46.85	3,039.66	3,069.38
Total Assets	47.88	18.75	46.92	6,523.10	8,653.35
Total Debt*	1.81	8.09	0.90	766.57	1,527.82
Net Current Assets	38.74	-3.03	46.16	1,587.38	1,790.64
Contingent Liabilities	1.09	--	0.41	34.20	0.53

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Cash From Operating Activities	-1.58	-0.96	2.11	382.01	538.95
Cash Flow from Investing Activities	2.01	-0.70	-20.97	-963.81	-668.65
Cash from Financing Activities	-3.44	1.40	43.67	590.26	193.35
Net Cash Inflow / Outflow	-3.01	-0.26	24.81	8.45	63.65

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
ROCE (%)	20.17	-29.88	2.44	22.42	11.58
ROE (%)	15.15	0.00	1.87	18.10	9.81
ROA (%)	12.73	-12.36	1.70	12.99	6.73
EBIT Margin (%)	24.48	1.04	10.02	24.32	13.23
Net Margin (%)	14.99	-7.41	6.98	15.63	6.93
Cash Profit Margin (%)	17.41	-3.77	7.56	17.66	9.76

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Revenue Growth (%)	5.10	155.17	-64.31	1.04	-4.77
EBIT Growth (%)	35.31	108.86	62.49	25.11	-11.47
Net Profit Growth (%)	36.33	63.59	68.04	36.02	-21.04
EPS Growth (%)	36.33	63.59	-42.03	32.34	-21.04
Book Value Growth (%)	14.95	-346.40	3,563.74	29.40	8.32

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Price / Earnings	5.80	0.00	141.99	29.64	31.90
Price / Book Value	0.82	-5.86	1.37	4.73	3.01
Dividend Yield (%)	1.89	0.00	0.00	0.18	0.58
EV/EBITDA	3.76	80.88	59.87	19.68	18.03
Market Cap (₹ Cr)	33.58	15.80	61.28	22,270.68	17,560.56

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Debt to Equity	0.04	-4.07	0.02	0.16	0.26
Short term debt to equity ratio	0.03	--	--	0.16	0.06
Current Ratio	6.87	0.77	67.45	2.09	2.40
Quick Ratio	6.64	0.51	67.45	1.57	1.73
Interest Coverage	18.46	-3.09	371.96	16.55	16.40

	Vasundhara Rasayan	Parmax Pharma	IEL	Himadri Speciality	Deepak Nitrite
Debtors to sales (%)	20.87	4.53	0.13	14.94	19.09
Asset Turnover	0.79	1.66	0.24	0.80	0.97
Receivable days	59.31	20.01	49.30	52.05	63.85
Inventory Days	17.38	36.94	0.00	52.79	41.09
Payable days	59.34	149.20	74.11	38.65	35.00
Cash Conversion Cycle	17.35	-92.25	-24.81	66.19	69.94

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.